IL-2-REGULATED EXPRESSION OF THE MONOCYTE CHEMOTACTIC PROTEIN-1 RECEPTOR (CCR2) IN HUMAN NK CELLS - CHARACTERIZATION OF A PREDOMINANT 3.4-KILOBASE TRANSCRIPT CONTAINING CCR2B AND CCR2A SEQUENCES
N. Polentarutti et al., IL-2-REGULATED EXPRESSION OF THE MONOCYTE CHEMOTACTIC PROTEIN-1 RECEPTOR (CCR2) IN HUMAN NK CELLS - CHARACTERIZATION OF A PREDOMINANT 3.4-KILOBASE TRANSCRIPT CONTAINING CCR2B AND CCR2A SEQUENCES, The Journal of immunology, 158(6), 1997, pp. 2689-2694
NK cells migrate in response to C-C chemokines, including monocyte che
motactic protein-1 (MCP-1) and MCP-3. Increased migration was observed
in IL-2-activated NK cells. It was therefore of interest to define th
e expression in resting and activated NK cells of the MCP-1 receptor (
CCR2) for which two cDNAs (A and B) have been described. Specific olig
onucleotides and reverse-transcriptase PCR revealed the presence in ac
tivated NK cells and mononuclear phagocytes of the fragments expected
on the basis of the reported cDNAs. In addition, amplification with a
common A/B- and an A-specific oligonucleotide yielded an unexpected, a
bundant, 1649-bp fragment. Sequence analysis as well as Northern blott
ing and RNase protection with different probes revealed that the CCR2
gene is expressed in activated NK cells and mononuclear phagocytes asa
predominant long transcript (3.4 kb) consisting of CCR2B, followed by
a novel sequence (X), corresponding to an intron in the genome, and b
y a CCR2A-specific portion. The predominant long transcript is polyade
nylated and present in the cytoplasm. The augmented migratory capacity
of IL-2 activated vs resting NK cells was associated with increased C
CR2 transcript levels.